Characterization of super responders to guselkumab treatment in moderate to severe psoriasis: Results from the VOYAGE 1 and 2 clinical trials

被引：0
|
作者：
Reich, Kristian [1 ,2 ]
Strober, Bruce [3 ,4 ]
Langley, Richard [5 ]
Song, Michael [6 ]
Shen, Yaung-Kaung [6 ]
You, Yin [6 ]
Foley, Peter [7 ,8 ]
Blauvelt, Andrew [9 ]
机构：
[1] Univ Med Ctr Hamburg Eppendorf, Inst Hlth Serv Res Dermatol & Nursing, Translat Res Inflammatory Skin Dis, Hamburg, Germany
[2] Skinflammat Ctr, Hamburg, Germany
[3] Yale Univ, New Haven, CT USA
[4] Cent Connecticut Dermatol Res, Cromwell, CT USA
[5] Dalhousie Univ, Halifax, NS, Canada
[6] Janssen Res & Dev, Beerse, Belgium
[7] Univ Melbourne, St Vincents Hosp Melbourne, Prob Med Res, Melbourne, Vic, Australia
[8] Skin & Canc Fdn, Melbourne, Vic, Australia
[9] Oregon Med Res Ctr, Portland, OR USA
来源：
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY | 2020年 / 83卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
15280
引用
收藏
页码：AB145 / AB145
页数：1
相关论文
共 50 条
  • [1] Characterization of super responders to guselkumab treatment in moderate-to-severe psoriasis: results from the VOYAGE 1 and 2 clinical trials
    Reich, K.
    Gordon, K. B.
    Strober, B.
    Langley, R. G.
    Song, M.
    Shen, Y-K
    You, Y.
    Foley, P.
    Blauvelt, A.
    [J]. AUSTRALASIAN JOURNAL OF DERMATOLOGY, 2021, 62 : 55 - 56
  • [2] Super responders to guselkumab treatment in moderate-to-severe psoriasis: a real clinical practice pilot series
    Ruiz-Villaverde, Ricardo
    Rodriguez-Fernandez-Freire, Lourdes
    Armario-Hita, Jose C.
    Perez-Gil, Amalia
    Galan-Gutierrez, Manuel
    [J]. INTERNATIONAL JOURNAL OF DERMATOLOGY, 2022, 61 (08) : 1029 - 1033
  • [3] The Impact of Treatment with Guselkumab on Skin-related Quality of Life in Male and Female Patients with Moderate to Severe Psoriasis: Results from the VOYAGE 1 and 2 Trials
    Armstrong, April
    Puig, Luis
    Papp, Kim A.
    Strauss, Marcie E.
    Yang, Ya-Wen
    Cheng, Ru-Fong
    Miller, Megan
    Murase, Jenny E.
    Fernandez-Penas, Pablo
    Han, Chenglong
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2023, 89 (03) : AB235 - AB235
  • [4] Continuous treatment with guselkumab maintains clinical responses through 4 years in patients with moderate-to-severe psoriasis: results from VOYAGE 1
    Griffiths, Christopher E. M.
    Papp, Kim A.
    Song, Michael
    Miller, Megan
    You, Yin
    Shen, Yaung-Kaung
    Han, Chenglong
    Blauvelt, Andrew
    [J]. JOURNAL OF DERMATOLOGICAL TREATMENT, 2022, 33 (02) : 848 - 856
  • [5] CLINICAL RESPONSE AFTER GUSELKUMAB TREATMENT AMONG ADALIMUMAB PASI 90 NON-RESPONDERS: RESULTS FROM THE VOYAGE 1 AND 2 TRIALS
    Griffith, Christopher
    Radtke, Marc Alexander
    Youn, Sang Woong
    Bissonnette, Robert
    Song, Michael
    Wasfi, Yasmine
    Randazzo, Bruce
    You, Yin
    Shen, Yaung-Kaung
    Strober, Bruce
    [J]. ACTA DERMATO-VENEREOLOGICA, 2018, 98 : 20 - 20
  • [6] Consistency of response (PASI 90 or 100 and IGA 0 or 0/1) in patients with moderate to severe psoriasis treated with guselkumab: Results from the VOYAGE 1 and 2 trials
    Gordon, Kenneth
    Menter, Alan
    Ferris, Laura
    Martorell, Antonio
    Kim, Byung Soo
    Song, Michael
    Wasfi, Yasmine
    You, Yin
    Shen, Yaung-Kaung
    Langley, Richard
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2018, 79 (03) : AB87 - AB87
  • [7] Super-Responders in Moderate-Severe Psoriasis under Guselkumab Treatment: Myths, Realities and Future Perspectives
    Ruiz-Villaverde, Ricardo
    Vasquez-Chinchay, Fiorella
    Rodriguez-Fernandez-Freire, Lourdes
    Armario-Hita, Jose C.
    Perez-Gil, Amalia
    Galan-Gutierrez, Manuel
    [J]. LIFE-BASEL, 2022, 12 (09):
  • [8] Malignancy rates through 5 years of follow-up in patients with moderate-to-severe psoriasis treated with guselkumab: Pooled results from the VOYAGE 1 and VOYAGE 2 trials
    Blauvelt, Andrew
    Lebwohl, Mark
    Langley, Richard G.
    Rowland, Katelyn
    Yang, Ya-Wen
    Chan, Daphne
    Miller, Megan
    You, Yin
    Yu, Jenny
    Thaci, Diamant
    Foley, Peter
    Papp, Kim A.
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2023, 89 (02) : 274 - 282
  • [9] Safety of guselkumab in patients with psoriasis with a history of malignancy: 5-year results from the VOYAGE 1 and VOYAGE 2 trials
    Blauvelt, Andrew
    Thaci, Diamant
    Papp, Kim A.
    Ho, Vincent
    Ghoreschi, Kamran
    Kim, Byung Soo
    Miller, Megan
    Shen, Yaung-Kaung
    You, Yin
    Chan, Daphne
    Yu, Jenny
    Yang, Ya-Wen
    Lebwohl, Mark G.
    Gottlieb, Alice B.
    Crowley, Jeffrey
    Foley, Peter
    [J]. BRITISH JOURNAL OF DERMATOLOGY, 2023, 189 (01) : 132 - 134
  • [10] Immunogenicity and pharmacokinetics of guselkumab among patients with moderate-to-severe psoriasis in VOYAGE-1 and VOYAGE-2
    Armstrong, A.
    Eyerich, K.
    Conrad, C.
    Zhu, Y.
    Yang, Y. -w.
    Miller, M.
    You, Y.
    Shen, Y. -k.
    Foley, P.
    Griffiths, C. E. M.
    Strober, B.
    [J]. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2023, 37 (12) : E1375 - E1379
12345